ClearPoint Neuro, Inc.: 10-Q filed 2015-11-13
What ClearPoint Neuro, Inc. reported in its quarterly report filed 2015-11-13 (fiscal Q3 2015): 27 published measures, 71 facts as tagged in accession 0001534424-15-000367.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-11-13
- Fiscal period
- fiscal Q3 2015
- Accession
- 0001534424-15-000367 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ClearPoint Neuro, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 6,273,128 | USD | |
| At 2014-12-31 | 13,385,682 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 12,095,500 | USD | |
| At 2014-12-31 | 13,486,012 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | -5,822,372 | USD | |
| At 2014-12-31 | -100,330 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 1,851,862 | USD | |
| At 2014-12-31 | 9,244,006 | USD | |
| At 2014-09-30 | 1,894,681 | USD | |
| At 2013-12-31 | 3,516,244 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -245,399 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -7,250,811 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -3,647,222 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -2,609,920 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 72,021 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 11,590 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 1,246,434 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 3,082,578 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 633,204 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 2,644,640 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | -84,528,144 | USD | |
| At 2014-12-31 | -77,277,334 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 495,084 | USD | |
| At 2014-12-31 | 482,970 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 268,880 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 1,421,198 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 192,001 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 555,909 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -1,927,017 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -7,554,382 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -2,618,323 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -2,641,882 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 4,625,462 | USD | |
| At 2014-12-31 | 11,707,214 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 316,705 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 936,043 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 288,783 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 723,886 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 7,745,495 | USD | |
| At 2014-12-31 | 4,919,318 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 640,637 | USD | |
| At 2014-12-31 | 997,090 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 837,441 | USD | |
| At 2014-12-31 | 468,949 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 1,802,818 | USD | |
| At 2014-12-31 | 1,965,039 | USD |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 2,132,777 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 6,608,829 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 2,062,309 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 5,792,241 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 480,280 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 1,434,723 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 873,366 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 2,589,410 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 74,971,026 | shares | |
| At 2014-12-31 | 74,842,428 | shares |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 7,996,483 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 232,982 | USD | |
| At 2014-12-31 | 285,498 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 133,341 | USD | |
| At 2014-12-31 | 29,220 | USD |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 153,545 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 294,639 | USD | 273 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 45,302 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 243,505 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 38,237 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 167,614 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 368,492 | USD | 273 |
| 2014-01-01 to 2014-09-30 | -221,586 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | -83,987 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 657,948 | USD | 273 |
Inspect the source
- Entity
- ClearPoint Neuro, Inc. / CIK 0001285550
- Captured
- 2026-09-20T07:49:10.325Z
- SEC response SHA-256
42cce1b4fae43ade1c2eab56e81afab6eae0d04e4ec290dc982d64b677ec31fb
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001285550.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))